MyFinsight
Home
Blog
About
Contact
Download
Download image
Net sales
$66,551K
Gross profit
$48,396K
Canceled cashflow
$18,155K
Net income
$15,679K
Depreciation and
amortization
$2,623K
Stock-based compensation
$2,092K
Prepaid expenses and
other assets
-$1,038K
Provision for inventory
write-downs
$761K
Amortization of issuance
costs on convertible...
$222K
Foreign currency
transaction effect on income
-$71K
Canceled cashflow
$32,717K
Cost of sales
$18,155K
Net cash provided by
operating activities
$15,093K
Canceled cashflow
$7,393K
Selling expense
$12,800K
Administrative expense
$7,963K
Finance expense
$3,184K
Other (income)
expense, net
-$2,096K
Marketing expense
$1,715K
Regulatory and clinical
expense
$1,635K
Research and development
expense
$1,423K
Process engineering
expense
$1,002K
Management information
systems expense
$899K
Net increase
(decrease) in cash and cash...
-$1,393K
Canceled cashflow
$15,093K
Proceeds from sales of
short-term marketable...
$140,573K
Proceeds from stock
option exercises
$2,952K
Accounts receivable
$2,481K
Accounts payable and
other liabilities
-$2,340K
Inventory and other
deferred costs
$1,392K
Accrued interest
-$1,078K
Non-cash investment
income
$102K
Net cash used in
investing activities
-$13,121K
Canceled cashflow
$140,573K
Net cash used in
financing activities
-$3,219K
Effect of exchange rate
changes on cash and cash...
-$146K
Canceled cashflow
$2,952K
Purchases of short-term
marketable securities
$150,866K
Purchases of property and
equipment
$2,783K
Payments related to
acquisitions, net of cash...
$45K
Common stock cash
dividend paid
$5,711K
Payment of withholding
taxes in connection...
$460K
Back
Back
Cash Flow
LEMAITRE VASCULAR INC (LMAT)
LEMAITRE VASCULAR INC (LMAT)
source: myfinsight.com